SCHEMBL806486

SCHEMBL806486

Cc1ccc(OC(N)(N)N)c(CO)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 2/20 0.36
LMNA P02545 1/20 0.36
ACHE P22303 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35
SLC13A5 Q86YT5 1/20 0.35
MAPK8 P45983 1/20 0.34
AMY1A P0DUB6 1/20 0.33
POLB P06746 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
HTR2A P28223 1/20 0.33
SLC6A4 P31645 1/20 0.33
KCNH2 Q12809 1/20 0.33
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9071417 0.82 GRM2 (0.39) ALDH1A1MAPTLMNAACHESLC13A5
SCHEMBL697285 0.77 ACHE (0.56) ALDH1A1CYP3A4MAPTLMNAACHE
SCHEMBL13717048 0.76 TRPA1 (0.46) ALDH1A1CYP3A4MAPTLMNAACHE
SCHEMBL11718647 0.76 MAPT (0.44) ALDH1A1MAPTLMNAACHEAMY1A
SCHEMBL13463122 0.75 ALDH1A1 (0.42) ALDH1A1CYP3A4MAPTACHECA1
SCHEMBL12527285 0.74 MAPT (0.57) ALDH1A1MAPTLMNAPOLBPTGDR2
SCHEMBL14254191 0.73 ALDH1A1 (0.45) ALDH1A1MAPTLMNAPOLBPTGDR2
SCHEMBL12180330 0.73 FFAR4 (0.48) ALDH1A1MAPTLMNAACHEPOLB
SCHEMBL11576590 0.73 SLC6A4 (0.53) ALDH1A1MAPTLMNAPOLBHTR2A
SCHEMBL7473992 0.71 ALDH1A1 (0.48) ALDH1A1MAPTLMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012036253-A1 HETEROCYCLIC COMPOUNDS FOR TREATING OR PREVENTING DISORDERS CAUSED BY REDUCED NEUROTRANSMISSION OF SEROTONIN, NOREPHNEPHRINE OR DOPAMINE. OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2012-03-22 WO disclosed